Expanded Access Program for olaparib tablets as maintenance therapy in patients with ovarian, fallopian tube or primary peritoneal cancer.

Trial Identifier: D0816R00014
Sponsor: AstraZeneca
Collaborator:
PAREXEL
NCTID:: NCT03079687
Condition: Ovarian Cancer

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
United States of America, CA Duarte, CA, United States of America, 91010
United States of America, CA Newport Beach, CA, United States of America, 92663
United States of America, CA Roseville, CA, United States of America, 95661
United States of America, FL Gainesville, FL, United States of America, 32608
United States of America, MD Baltimore, MD, United States of America, 21201
United States of America, ME Scarborough, ME, United States of America, 04074
United States of America, MN Rochester, MN, United States of America, 55905
United States of America, MO Columbia, MO, United States of America, 65212
United States of America, NC Durham, NC, United States of America, 27710
United States of America, NC Winston-Salem, NC, United States of America, 27157-1023
United States of America, NM Albuquerque, NM, United States of America, 87106
United States of America, OH Cleveland,, OH, United States of America, 44195
United States of America, OR Portland, OR, United States of America, 97239